Naomi Hunder serves as Executive at Silverback Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Naomi Hunder has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 2, 2022 involved receiving (via award) 43,177 shares valued at $0.
Naomi Hunder currently holds 54,427 shares of Silverback Therapeutics, Inc. (SBTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Naomi Hunder has been a net neutral trader of SBTX stock. They have purchased $0 and sold $0 worth of shares.
Naomi Hunder's most recent insider trade was on May 2, 2022, when they sold 43,177 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |